Table 1 Correlation of SLC6A14 expression with clinicopathological features of PC.
Characteristic | Low expression of SLC6A14 | High expression of SLC6A14 | P |
|---|---|---|---|
n | 89 | 89 | |
Gender, n (%) | 0.097 | ||
Female | 34 (19.1%) | 46 (25.8%) | |
Male | 55 (30.9%) | 43 (24.2%) | |
Age, n (%) | 0.072 | ||
< = 65 | 53 (29.8%) | 40 (22.5%) | |
> 65 | 36 (20.2%) | 49 (27.5%) | |
Pathologic stage, n (%) | 0.320 | ||
Stage I | 14 (8%) | 7 (4%) | |
Stage II | 69 (39.4%) | 77 (44%) | |
Stage III | 1 (0.6%) | 2 (1.1%) | |
Stage IV | 3 (1.7%) | 2 (1.1%) | |
Histologic grade, n (%) | 0.060 | ||
G1 | 21 (11.9%) | 10 (5.7%) | |
G2 | 44 (25%) | 51 (29%) | |
G3 | 21 (11.9%) | 27 (15.3%) | |
G4 | 2 (1.1%) | 0 (0%) | |
Age, mean ± SD | 63.03 ± 10.2 | 66.46 ± 11.16 | 0.034 |
